1. Home
  2. SXC vs FDMT Comparison

SXC vs FDMT Comparison

Compare SXC & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SunCoke Energy Inc.

SXC

SunCoke Energy Inc.

HOLD

Current Price

$5.99

Market Cap

516.5M

Sector

Industrials

ML Signal

HOLD

Logo 4D Molecular Therapeutics Inc.

FDMT

4D Molecular Therapeutics Inc.

HOLD

Current Price

$8.35

Market Cap

513.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SXC
FDMT
Founded
1960
2013
Country
United States
United States
Employees
848
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
516.5M
513.6M
IPO Year
2011
2019

Fundamental Metrics

Financial Performance
Metric
SXC
FDMT
Price
$5.99
$8.35
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$9.00
$32.40
AVG Volume (30 Days)
1.9M
674.7K
Earning Date
05-20-2026
04-13-2026
Dividend Yield
7.75%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,600,300,000.00
$37,000.00
Revenue This Year
N/A
$21,227.03
Revenue Next Year
$4.74
$161.87
P/E Ratio
N/A
N/A
Revenue Growth
10.30
N/A
52 Week Low
$5.52
$2.24
52 Week High
$9.82
$12.34

Technical Indicators

Market Signals
Indicator
SXC
FDMT
Relative Strength Index (RSI) 38.91 42.07
Support Level $5.52 $8.15
Resistance Level $6.97 $8.80
Average True Range (ATR) 0.30 0.55
MACD 0.04 -0.12
Stochastic Oscillator 46.38 7.86

Price Performance

Historical Comparison
SXC
FDMT

About SXC SunCoke Energy Inc.

SunCoke Energy Inc operates as an independent producer of coke in the Americas. Its coke is mainly used as a principal raw material in the blast furnace steelmaking process as well as in the foundry production of casted iron. The company operates through two segments: Domestic Coke and Industrial Services. It offers metallurgical and thermal coal. The company also provides handling and/or mixing services to steel, coke, electric utility, coal-producing, and other manufacturing-based customers. The majority of revenue is derived from the Domestic Coke segment.

About FDMT 4D Molecular Therapeutics Inc.

4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.

Share on Social Networks: